liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population
Karolinska Institute, Sweden; Karolinska University Hospital, Sweden.
Sahlgrens University Hospital, Sweden; University of Gothenburg, Sweden.
Uppsala University, Sweden.
Umeå University, Sweden.
Show others and affiliations
2016 (English)In: Oncology Reports, ISSN 1021-335X, E-ISSN 1791-2431, Vol. 36, no 5, 2823-2835 p.Article in journal (Refereed) Published
Abstract [en]

Lynch syndrome caused by constitutional mismatch-repair defects is one of the most common hereditary cancer syndromes with a high risk for colorectal, endometrial, ovarian and urothelial cancer. Lynch syndrome is caused by mutations in the mismatch repair (MMR) genes i.e., MLH1, MSH2, MSH6 and PMS2. After 20 years of genetic counseling and genetic testing for Lynch syndrome, we have compiled the mutation spectrum in Sweden with the aim to provide a population-based perspective on the contribution from the different MMR genes, the various types of mutations and the influence from founder mutations. Mutation data were collected on a national basis from all laboratories involved in genetic testing. Mutation analyses were performed using mainly Sanger sequencing and multiplex ligation-dependent probe amplification. A total of 201 unique disease-predisposing MMR gene mutations were identified in 369 Lynch syndrome families. These mutations affected MLH1 in 40%, MSH2 in 36%, MSH6 in 18% and PMS2 in 6% of the families. A large variety of mutations were identified with splice site mutations being the most common mutation type in MLH1 and frameshift mutations predominating in MSH2 and MSH6. Large deletions of one or several exons accounted for 21% of the mutations in MLH1 and MSH2 and 22% in PMS2, but were rare (4%) in MSH6. In 66% of the Lynch syndrome families the variants identified were private and the effect from founder mutations was limited and predominantly related to a Finnish founder mutation that accounted for 15% of the families with mutations in MLH1. In conclusion, the Swedish Lynch syndrome mutation spectrum is diverse with private MMR gene mutations in two-thirds of the families, has a significant contribution from internationally recognized mutations and a limited effect from founder mutations.

Place, publisher, year, edition, pages
SPANDIDOS PUBL LTD , 2016. Vol. 36, no 5, 2823-2835 p.
Keyword [en]
HNPCC; MLH1; MSH2; MSH6; EPCAM; hereditary colorectal cancer; Lynch syndrome
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-132659DOI: 10.3892/or.2016.5060ISI: 000385992700047PubMedID: 27601186OAI: oai:DiVA.org:liu-132659DiVA: diva2:1048336
Note

Funding Agencies|Swedish Cancer Society

Available from: 2016-11-21 Created: 2016-11-18 Last updated: 2016-11-21

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Stenmark Askmalm, Marie
By organisation
Division of Cell BiologyFaculty of Medicine and Health SciencesDepartment of Clinical Pathology and Clinical Genetics
In the same journal
Oncology Reports
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 1 hits
ReferencesLink to record
Permanent link

Direct link